Cyclacel Pharmaceuticals CYCCP
$ 6.05
0.0%
Quarterly report 2024-Q3
added 11-12-2024
Cyclacel Pharmaceuticals Balance Sheet 2011-2024 | CYCCP
Annual Balance Sheet Cyclacel Pharmaceuticals
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-3.34 M | -18.2 M | -36.5 M | -32.3 M | -10.7 M | -17.4 M | -23.9 M | -16.5 M | -20.4 M | -24.2 M | -31.1 M | -16.4 M | -24.4 M |
Long Term Debt |
37 K | 106 K | 30 K | - | - | - | - | - | - | - | - | - | - |
Long Term Debt Current |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | 1.06 M | 1.19 M | 100 K | 124 K | 130 K | 176 K | 206 K | - | - | - |
Total Current Liabilities |
8.16 M | 7.51 M | 5.29 M | 2.49 M | 2.42 M | 4.45 M | 4.11 M | 5.26 M | 5.75 M | 7.49 M | 7.5 M | 9.34 M | 6.5 M |
Total Liabilities |
8.2 M | 7.62 M | 5.32 M | 3.54 M | 3.61 M | 4.55 M | 4.24 M | 5.39 M | 5.93 M | 7.7 M | 7.5 M | 9.34 M | 6.5 M |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-428 M | -406 M | -385 M | -366 M | -358 M | -350 M | -343 M | -335 M | -323 M | -309 M | -289 M | -270 M | -257 M |
Total Assets |
8.8 M | 28 M | 42.6 M | 36.8 M | 15.3 M | 19.8 M | 26 M | 19.7 M | 24.8 M | 29.4 M | 35.5 M | 19.4 M | 26 M |
Cash and Cash Equivalents |
3.38 M | 18.3 M | 36.6 M | 33.4 M | 11.9 M | 17.5 M | 23.9 M | 16.5 M | 20.4 M | 24.2 M | 31.1 M | 16.4 M | 24.4 M |
Book Value |
607 K | 20.4 M | 37.3 M | 33.3 M | 11.7 M | 15.3 M | 21.8 M | 14.3 M | 18.8 M | 21.7 M | 28 M | 10 M | 19.5 M |
Total Shareholders Equity |
607 K | 15.9 M | 37.3 M | 33.3 M | 11.7 M | 15.3 M | 21.8 M | 14.3 M | 18.8 M | 21.7 M | 28 M | 10 M | 19.5 M |
All numbers in USD currency
Quarterly Balance Sheet Cyclacel Pharmaceuticals
2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
- | 5 K | 21 K | 37 K | 66 K | 80 K | 106 K | 107 K | 113 K | 15 K | 30 K | 44 K | - | 996 K | 1.06 M | 1.06 M | 1.06 M | 1.06 M | 1.19 M | 1.19 M | 1.19 M | 1.19 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
6.35 M | 7.19 M | 8.37 M | 8.2 M | 6.81 M | 7.42 M | 7.5 M | 4.46 M | 5.14 M | 6.22 M | 5.32 M | 3.64 M | 3.12 M | 3.77 M | 3.54 M | 3.54 M | 3.54 M | 3.54 M | 3.61 M | 3.61 M | 3.61 M | 3.61 M | 4.55 M | 4.55 M | 4.55 M | 4.55 M | 4.24 M | 4.24 M | 4.24 M | 4.24 M | 5.39 M | 5.39 M | 5.39 M | 5.39 M | 5.93 M | 5.93 M | 5.93 M | 5.93 M | 7.7 M | 7.7 M | 7.7 M | 7.7 M | 7.5 M | 7.5 M | 7.5 M | 7.5 M | 9.34 M | 9.34 M | 9.34 M | 9.34 M | 6.5 M | 6.5 M | 6.5 M | 6.5 M |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-436 M | -434 M | -431 M | -428 M | -417 M | -412 M | -406 M | -399 M | -394 M | -389 M | -385 M | -380 M | -375 M | -370 M | -366 M | -366 M | -366 M | -366 M | -358 M | -358 M | -358 M | -358 M | -350 M | -350 M | -350 M | -350 M | -343 M | -343 M | -343 M | -343 M | -335 M | -335 M | -335 M | -335 M | -323 M | -323 M | -323 M | -323 M | -309 M | -309 M | -309 M | -309 M | -289 M | -289 M | -289 M | -289 M | -270 M | -270 M | -270 M | -270 M | -257 M | -257 M | -257 M | -257 M |
Total Assets |
5.38 M | 8.19 M | 6.16 M | 8.8 M | 16.4 M | 22.1 M | 27.5 M | 31 M | 35.3 M | 39.6 M | 42.6 M | 45 M | 46.3 M | 51.8 M | 36.8 M | 36.8 M | 36.8 M | 36.8 M | 15.3 M | 15.3 M | 15.3 M | 15.3 M | 19.8 M | 19.8 M | 19.8 M | 19.8 M | 26 M | 26 M | 26 M | 26 M | 19.7 M | 19.7 M | 19.7 M | 19.7 M | 24.8 M | 24.8 M | 24.8 M | 24.8 M | 29.4 M | 29.4 M | 29.4 M | 29.4 M | 35.5 M | 35.5 M | 35.5 M | 35.5 M | 19.4 M | 19.4 M | 19.4 M | 19.4 M | 26 M | 26 M | 26 M | 26 M |
Cash and Cash Equivalents |
2.98 M | 6 M | 2.8 M | 3.38 M | 10.2 M | 11.4 M | 18.3 M | 23.7 M | 29.1 M | 29.6 M | 36.6 M | 40.2 M | 43.6 M | 47.8 M | 33.4 M | 33.4 M | 33.4 M | 33.4 M | 11.9 M | 11.9 M | 11.9 M | 11.9 M | 17.5 M | 17.5 M | 17.5 M | 17.5 M | 23.9 M | 23.9 M | 23.9 M | 23.9 M | 16.5 M | 16.5 M | 16.5 M | 16.5 M | 20.4 M | 20.4 M | 20.4 M | 20.4 M | 24.2 M | 24.2 M | 24.2 M | 24.2 M | 31.1 M | 31.1 M | 31.1 M | 31.1 M | 16.4 M | 16.4 M | 16.4 M | 16.4 M | 24.4 M | 24.4 M | 24.4 M | 24.4 M |
Book Value |
-970 K | 999 K | -2.21 M | 607 K | 9.63 M | 14.6 M | 20 M | 26.6 M | 30.2 M | 33.4 M | 37.3 M | 41.4 M | 43.2 M | 48 M | 33.3 M | 33.3 M | 33.3 M | 33.3 M | 11.7 M | 11.7 M | 11.7 M | 11.7 M | 15.3 M | 15.3 M | 15.3 M | 15.3 M | 21.8 M | 21.8 M | 21.8 M | 21.8 M | 14.3 M | 14.3 M | 14.3 M | 14.3 M | 18.8 M | 18.8 M | 18.8 M | 18.8 M | 21.7 M | 21.7 M | 21.7 M | 21.7 M | 28 M | 28 M | 28 M | 28 M | 10 M | 10 M | 10 M | 10 M | 19.5 M | 19.5 M | 19.5 M | 19.5 M |
Total Shareholders Equity |
-970 K | 999 K | -2.21 M | 607 K | 5.14 M | 10.1 M | 15.5 M | 22.1 M | 30.2 M | 33.4 M | 37.3 M | 41.4 M | 43.2 M | 48 M | 33.3 M | 33.3 M | 33.3 M | 33.3 M | 11.7 M | 11.7 M | 11.7 M | 11.7 M | 15.3 M | 15.3 M | 15.3 M | 15.3 M | 21.8 M | 21.8 M | 21.8 M | 21.8 M | 14.3 M | 14.3 M | 14.3 M | 14.3 M | 18.8 M | 18.8 M | 18.8 M | 18.8 M | 21.7 M | 21.7 M | 21.7 M | 21.7 M | 28 M | 28 M | 28 M | 28 M | 10 M | 10 M | 10 M | 10 M | 19.5 M | 19.5 M | 19.5 M | 19.5 M |
All numbers in USD currency